ARMO BioSciences, Inc. License Agreements
3 Contracts & Agreements
- Amendment No. 2 to the Exclusive Patent License between Merck, Sharpe & Dohm Corporation and the Registrant, dated July 11, 2017 (Filed With SEC on December 29, 2017)
- Amendment No. 1 to the Exclusive Patent License between Merck, Sharp & Dohme Corporation and the Registrant, dated December 12, 2012 (Filed With SEC on December 29, 2017)
- Exclusive Patent License Agreement, dated December 12, 2012, between Merck, Sharp & Dohme Corporation and the Registrant (Filed With SEC on December 29, 2017)
